$2.85
-0.08 (-2.73%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+410.2% upside
Low Target
$12.76
Average Target
$14.54
High Target
$24.66
Current Price
$2.85
Current
$2.85
$2.85
Target
$14.54
$14.54
$12.76
$14.54 avg
$24.66
Scenario Analysis
Bear Case
$12.76
347.7%
Low target
Base Case
$14.54
+410.2%
Avg target
Bull Case
$24.66
+765.3%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$11.37
-74.9% from high
52-Week Low
$2.87
+-0.7% from low
Target vs 52W High
$14.54
+27.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |